Vascular Endothelial Growth Factor Receptor-3 Expression Predicts Sentinel Node Status in Primary Cutaneous Melanoma
Acta Dermato VenereologicaPublished 1 January 2020Open access
Ferdinand Toberer, Holger A. Haenssle, Martin Laimer, Monika Heinzel‐Gutenbrunner, Alexander Enk, Wolfgang Hartschuh
Citations8
SJR quartileQ1
SJR score1.03
SNIP1.05
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Evidence is provided that VEGFR-3 expression may play a critical role in the pathogenesis of malignant melanoma and that its investigation may help to improve the selection of patients with primary cutaneous melanoma for sentinel node biopsy.
Abstract
This study analysed the expression of vascular endothelial growth factor-A (VEGF), VEGFR-2, and VEGFR-3 in primary cutaneous melanomas with positive and negative sentinel node status (SLN) (a total of 58 specimens divided into 2 groups of 29 for each status). The specimens were collected from the pathological archive of the department of Dermatology, Venereology and Allergology of the University Medical Center Heidelberg. A quantification score was developed for protein expression, by considering the percentage of positive melanoma cells (0: 0%, 1: up to 1%, 2: 2-10%, 3: 11-50%, and 4: > 50%) in relation to the intensity of staining (0: negative, 1: low, 2: medium, 3: strong). Tumoural VEGFR-3 expression (mean ± standard deviation) in SLN+ tumours (9.62 ± 3.09) was significantly stronger than in SLN- tumours (6.13 ± 3.87; p < 0.001). A binary logistic regression model proved VEGFR-3 expression and tumour thickness to be significant independent predictors of SLN. These data provide evidence that VEGFR-3 expression may play a critical role in the pathogenesis of malignant melanoma and that its investigation may help to improve the selection of patients with primary cutaneous melanoma for sentinel node biopsy.
Keywords
MedicineEngineering
CA A Cancer Journal for CliniciansCancer statistics, 2017
14,971 Citations2017Rebecca L. Siegel, Kimberly D. Miller +1 more
The American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.
New England Journal of MedicineFinal Trial Report of Sentinel-Node Biopsy versus Nodal Observation in Melanoma
1,420 Citations2014Donald L. Morton, John F. Thompson +16 more
Biopsy-based staging of intermediate-thickness or thick primary melanomas provides important prognostic information and identifies patients with nodal metastases who may benefit from immediate complete lymphadenectomy, and prolongs disease-free survival and melanoma-specific survival.
Annals of SurgerySentinel Node Biopsy for Early-Stage Melanoma
711 Citations2005Donald L. Morton, Alistair J. Cochran +12 more
LM/SNB is a safe, low-morbidity procedure for staging the regional nodal basin in early melanoma and should become standard care for stagingThe regional lymph nodes of patients with primary cutaneous melanoma.
Annals of Surgical OncologySentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program Experience
333 Citations2000Natale Cascinelli, Filiberto Belli +11 more
These data confirm the feasibility and safety of the SLN technique for selecting patients to submit to a radical node dissection and represent the basis for a future trial by the WHO Melanoma Program in this field to evaluate the most appropriate surgical approach for treating patients with occult regional nodal metastases.
Clinical Cancer ResearchVascular Endothelial Growth Factor Receptors VEGFR-2 and VEGFR-3 Are Localized Primarily to the Vasculature in Human Primary Solid Cancers
237 Citations2010Neil R. Smith, Dawn Baker +10 more
The upregulation of VEG FR-3 on tumor blood vessels indicates a potential additional antiangiogenic effect for dual VEGFR-2/VEGFR-3–targeted therapy.
Annals of Surgical OncologySentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline Update
156 Citations2017Sandra L. Wong, Mark B. Faries +13 more
An ASCO-SSO panel was formed, and a systematic review of the literature was conducted regarding SLN biopsy and completion lymph node dissection (CLND) after a positive sentinel node in patients with melanoma.
American Journal Of PathologyExpresson of Vascular Endothelial Growth Factor, Its Receptors (FLT-1, KDR) and TSP-1 Related to Microvessel Density and Patient Outcome in Vertical Growth Phase Melanomas
154 Citations2001Oddbjørn Straume, Lars A. Akslen
The data suggest that MVD is associated with prognosis in cutaneous melanomas, and that the VEGF system and particularly TSP-1 seem to be involved in the regulation of angiogenesis and progression of these tumors.
European Journal of Surgical OncologyComplications of sentinel lymph node biopsy for melanoma – A systematic review of the literature
115 Citations2016J.A. Moody, Rabia Ali +3 more
Information about the incidence of complications after sentinel lymph node biopsy for melanoma can be used to counsel patients about the procedure and it sets a benchmark against which surgeons can audit their practice.
The American Journal of Surgical PathologyVascular Endothelial Growth Factor Receptor 2 as a Marker for Malignant Vascular Tumors and Mesothelioma
108 Citations2012Markku Miettinen, Maarit-Sarlomo Rikala +3 more
VEGFR2 is a promising marker for malignant vascular tumors and malignant epithelioid mesothelioma and information on VEGFR2 tissue expression may be useful in development of targeted oncologic therapy through V EGFR2-specific tyrosine kinase inhibitors.
Annals of Surgical OncologyQuality of Life After Axillary or Groin Sentinel Lymph Node Biopsy, With or Without Completion Lymph Node Dissection, in Patients With Cutaneous Melanoma
104 Citations2009M. de Vries, Harald J. Hoekstra +1 more
QoL in melanoma survivors after axillary or inguinal SLNB with or without CLND was better than that in a norm group and by comparing QoL between four patient groups depending on surgical procedure and location.
Human PathologyQuantitative expression of VEGF, VEGF-R1, VEGF-R2, and VEGF-R3 in melanoma tissue microarrays
103 Citations2009Janice M. Mehnert, Mary M. McCarthy +6 more
Clinical trials using antiangiogenic agents in melanoma should include correlative assays of VEGF, V EGF-R1, VEGFs-R2, and VEGf-R3 as biomarkers of response to therapy, preferably using quantitative methods such as automated quantitative analysis.
PubMedVascular endothelial growth factor production in normal epidermis and in benign and malignant epithelial skin tumors.
99 Citations1996Wolfgang Weninger, Aumaid Uthman +8 more
The data demonstrate that VEGF production by tumor cells in situ does not distinguish malignant from benign epithelial tumors of the skin because it is present in both, and suggests that this angiotropic cytokine is important for the regulation of vessel function under physiologic conditions.
CancerImmunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions
97 Citations2002Oriana Simonetti, Guendalina Lucarini +5 more
Vascular endothelial growth factor (VEGF), an endothelial cell mitogen, plays a hierarchical role in regulating physiologic and pathologic angiogenesis and is implicated in tumor cell invasion.
Archives of Dermatological ResearchExpression of vascular endothelial growth factor in normal epidermis, epithelial tumors and cultured keratinocytes
96 Citations1997J. Viac, Sarah Brandão Palácio +2 more
Results showed a modulated expression and release of VEGF in relation to the stage of cell differentiation and in rapidly growing or activated keratinocytes in normal skin, benign and malignant epithelial lesions and cultured keratinocyte cultures.
PubMedInduction of vascular endothelial growth factor receptor-3 expression on tumor microvasculature as a new progression marker in human cutaneous melanoma.
76 Citations2002Ruud Clarijs, Lia Schalkwijk +3 more
It is demonstrated that lymphatic endothelium can reliably be identified in a panel of different normal tissues and of benign and malignant tumors and proposed VEGFR-3 expression as a new microvascular progression marker in cutaneous melanoma.
European Journal of Surgical OncologySentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free
75 Citations2004Nir Wasserberg, Hagit Tulchinsky +3 more
Wound complications are more frequent than usually reported and neck SLNB is associated with the highest rate of identification failure, and patient age, basin location, and number of excised nodes may serve as prognostic factors of morbidity.
Journal of Skin CancerMultiple Roles for VEGF in Non-Melanoma Skin Cancer: Angiogenesis and Beyond
65 Citations2012Kelly E. Johnson, Traci A. Wilgus
New studies show that VEGF carries out functions beyond its well-established effects on angiogenesis and highlight the need to consider these alternative activities when developing new treatments for non-melanoma skin cancer.
PubMedVascular endothelial growth factor expression in malignant melanoma: prognostic versus diagnostic usefulness.
62 Citations1999IB Bayer‐Garner, Hough Aj +1 more
Although VEGF is not a useful prognostic indicator for malignant melanoma, it may be useful as a discriminating factor between malignant and benign melanocytic lesions, and it may offer some insight into tumor growth.
PubMedVascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
61 Citations2003James S. Goydos, David H. Gorski
High levels of VEGF-C may be important in regional lymphatic disease in melanoma and that VEGf-C and LYVE-1 levels may identify tumors with a high risk for nodal metastases, for which antilymphangiogenic therapy may be more effective.
Cancer MedicineSurvival analysis and sentinel lymph node status in thin cutaneous melanoma: A multicenter observational study
60 Citations2019A. Tejera‐Vaquerizo, Simone Ribero +34 more
SLN status was the most important prognostic factor for melanoma‐specific survival and sex, ulceration, and Clark level for patients who underwent SLNB and should be discussed and recommended in patients with thin melanoma and a high mitotic rate.
Clinica Chimica ActaPathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis
55 Citations2016Jingwen Wang, Yühong Huang +7 more
This review summarizes the structure and function features of pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis, the expression changes of these molecules in different anatomic organs or histopathologic types or development stages of various tumors, the characteristics of transduction, implementation, integration of signal networks, and their molecular mechanisms and significances in tumor lymphangiogenesis and lymphatic metastasis.
CancerExpression of vascular endothelial growth factor in early cutaneous melanocytic lesion progression
51 Citations2007Janine G. Einspahr, Tracy Thomas +9 more
A considerable body of evidence supports the concept that a significant number of cutaneous malignant melanomas progress through a precursor lesion or dysplastic melanocytic nevi (DN).
Clinical and Experimental DermatologyExpression and localization of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 in human epidermal appendages: a comparison study by immunofluorescence
50 Citations2009Xiao‐Yong Man, Xiaohong Yang +5 more
This work has shown that keratinocytes from human normal skin express VEGFRs, and poses the question of whether these receptors are also expressed by epidermal appendages, as epider mal appendages are lined with epithelial cells.
Journal of the American Academy of DermatologyImmunologic escape and angiogenesis in human malignant melanoma
49 Citations2003Pedro Redondo, I. Sánchez‐Carpintero +4 more
Inverse plasma levels between IL-10 and VEGF in patients with metastatic melanoma are shown in vivo for the first time, the significance of which must be further investigated.
Journal of Plastic Reconstructive & Aesthetic SurgeryCurrent role of sentinel lymph node biopsy in the management of cutaneous melanoma: A UK consensus statement
47 Citations2019A. Howard S. Peach, Ruth Board +16 more
A multi-disciplinary consensus meeting involving many melanoma experts from the UK was convened in May 2018 and the conclusions reached were agreed by the clinicians attending the meeting and then externally peer reviewed.
Melanoma ResearchVEGF and VEGFR-2 immunohistochemistry in human melanocytic naevi and cutaneous melanomas
45 Citations2005Alberto Pisacane, Mauro Risio
PathologyThe correlation of angiogenesis with metastasis in primary cutaneous melanoma: a comparative analysis of microvessel density, expression of vascular endothelial growth factor and basic fibroblastic growth factor
40 Citations2006Cüyan Demirkesen, Nur Büyükpınarbaşılı +4 more
Microvessel density as well as the expression of both VEGF and bFGF might be informative concerning the progression of melanoma.
Annals of Surgical OncologyAge and Lymphovascular Invasion Accurately Predict Sentinel Lymph Node Metastasis in T2 Melanoma Patients
28 Citations2019Michael E. Egger, Megan Stevenson +6 more
This prediction model can inform shared decision-making regarding whether to perform SLN biopsy for older patients with otherwise low-risk T2 melanoma and younger age and LVI are powerful predictors of SLN metastases for patients with T1 melanoma.
Archives of Dermatological ResearchExpression pattern of the lymphatic and vascular markers VEGFR-3 and CD31 does not predict regional lymph node metastasis in cutaneous melanoma
20 Citations2006Marion Wobser, Claudia Siedel +4 more
VEGFR-3/CD31 immunohistochemical staining of primary melanoma does not serve as a valid marker to predict lymph node involvement and several different biomarkers have to be combined to define new prognostic subgroups in cutaneous melanoma.
PLoS ONEBRAF immunohistochemistry predicts sentinel lymph node involvement in intermediate thickness melanomas
10 Citations2019Atte A. Manninen, Maria Gardberg +5 more
Results demonstrate that BRAF immunohistochemistry could serve as a useful addition to a marker panel for selecting intermediate thickness melanoma patients for SNB, and identify a group of superficially spreading melanomas with an excellent survival probability independent of SNB status.
European Journal of CancerProbability of sentinel lymph node positivity in melanoma
3 Citations2019Mary‐Ann El Sharouni, Arjen J. Witkamp +2 more